IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - CDE, China Approved 'Metformin Hydrochloride'
CDE, China approved "Metformin Hydrochloride"19-02-2024
19-02-2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Conference Call, post declaration of audited financial results for the quarter and nine months ended 31st December 202314-02-2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of confirmation in lieu of lost share certificate13-02-2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Communication To Shareholders - Deduction Of Tax At Source On Interim Dividend For FY 2023-24
Communication to shareholders - Deduction of tax at source on Interim Dividend for FY 2023-2410-02-2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q3 & 9M FY2408-02-2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation - Q3 & M9 FY2407-02-2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspapers publication of Audited Financial Results for the quarter and nine months ended 31st December 202307-02-2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release: Financial Results for the quarter and nine months ended 31st December 202306-02-2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Corporate Action-Board approves Dividend
The Board of Directors in its meeting held on 6th February 2024 declared an Interim dividend of Rs 5/- (50%) per equity share of face value of Rs 10/-each for the Financial year 2023-2406-02-2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Outcome for Outcome Of The Board Meeting 06Th February 2024
Pursuant to Regulations 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 6th February 2024 has inter alia considered and approved: 1. The Standalone & Consolidated Audited Financial Results for the quarter and nine months ended 31st December 2023. Copy of the said Financial Results along with unmodified Auditors Report thereon is enclosed herewith as 'Annexure - 1'. 2. Declared an Interim Dividend of Rs. 5/- (50%) per Equity Share of Face Value Rs.10/- each for the Financial Year 2023-24. 3. Fixed 16th February 2024 as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive the above said Interim Dividend. The payment of the Interim Dividend shall be made to the eligible shareholders with in 30 days of declaration of dividend. 4. Closing of M/s IOL Global Limited, UK, Wholly Owned Subsidiary of the Company.06-02-2024